RT Journal Article
T1 Sarcoma European and Latin American Network (SELNET) Recommendations on Prioritization in Sarcoma Care During the COVID-19 Pandemic
A1 Martin-Broto, Javier
A1 Hindi, Nadia
A1 Aguiar Jr, Samuel
A1 Badilla-González, Ronald
A1 Castro-Oliden, Victor
A1 Chacón, Matias
A1 Correa-Generoso, Raquel
A1 de Álava, Enrique
A1 Donati, Davide María
A1 Eriksson, Mikael
A1 Falla-Jimenez, Martin
A1 German, Gisela
A1 Gobo Silva, Maria Leticia
A1 Gouin, Francois
A1 Gronchi, Alessandro
A1 Haro-Varas, Juan Carlos
A1 Jiménez-Brenes, Natalia
A1 Kasper, Bernd
A1 Lopes de Mello, Celso Abdon
A1 Maki, Robert
A1 Martínez-Delgado, Paula
A1 Martínez-Said, Hector
A1 Martinez-Tlahuel, Jorge Luis
A1 Morales-Pérez, Jose Manuel
A1 Muñoz-Casares, Francisco Cristobal
A1 Nakagawa, Suely A.
A1 Ortiz-Cruz, Eduardo Jose
A1 Palmerini, Emanuela
A1 Patel, Shreyaskumar
A1 Moura, David S.
A1 Stacchiotti, Silvia
A1 Sunyach, Marie Pierre
A1 Valverde, Claudia M.
A1 Waisberg, Federico
A1 Blay, Jean-Yves
K1 COVID-19
K1 Sarcoma
K1 Guidelines
K1 Multidisciplinary
K1 Patient care
K1 Guías como asunto
K1 Atención al paciente
K1 Directrices para la planificación en salud
AB Background: The COVID-19 outbreak has resulted in collision between patients infected with SARS-CoV-2 and those with cancer on different fronts. Patients with cancer have been impacted by deferral, modification, and even cessation of therapy. Adaptive measures to minimize hospital exposure, following the precautionary principle, have been proposed for cancer care during COVID-19 era. We present here a consensus on prioritizing recommendations across the continuum of sarcoma patient care.Material and methods: A total of 125 recommendations were proposed in soft-tissue, bone, and visceral sarcoma care. Recommendations were assigned as higher or lower priority if they cannot or can be postponed at least 2-3 months, respectively. The consensus level for each recommendation was classified as "strongly recommended" (SR) if more than 90% of experts agreed, "recommended" (R) if 75%-90% of experts agreed and "no consensus" (NC) if fewer than 75% agreed. Sarcoma experts from 11 countries within the Sarcoma European-Latin American Network (SELNET) consortium participated, including countries in the Americas and Europe. The European Society for Medical Oncology-Magnitude of clinical benefit scale was applied to systemic-treatment recommendations to support prioritization.Results: There were 80 SRs, 35 Rs, and 10 NCs among the 125 recommendations issued and completed by 31 multidisciplinary sarcoma experts. The consensus was higher among the 75 higher-priority recommendations (85%, 12%, and 3% for SR, R, and NC, respectively) than in the 50 lower-priority recommendations (32%, 52%, and 16% for SR, R, and NC, respectively).Conclusion: The consensus on 115 of 125 recommendations indicates a high-level of convergence among experts. The SELNET consensus provides a tool for sarcoma multidisciplinary treatment committees during the COVID-19 outbreak.Implications for practice: The Sarcoma European-Latin American Network (SELNET) consensus on sarcoma prioritization care during the COVID-19 era issued 125 pragmatical recommendations distributed as higher or lower priority to protect critical decisions on sarcoma care during the COVID-19 pandemic. A multidisciplinary team from 11 countries reached consensus on 115 recommendations. The consensus was lower among lower-priority recommendations, which shows reticence to postpone actions even in indolent tumors. The European Society for Medical Oncology-Magnitude of Clinical Benefit scale was applied as support for prioritizing systemic treatment. Consensus on 115 of 125 recommendations indicates a high level of convergence among experts. The SELNET consensus provides a practice tool for guidance in the decisions of sarcoma multidisciplinary treatment committees during the COVID-19 outbreak.
PB Wiley Periodicals LLC on behalf of AlphaMed Press.
SN 1083-7159
YR 2020
FD 2020-09-05
LK http://hdl.handle.net/10668/3283
UL http://hdl.handle.net/10668/3283
LA spa
NO Martin-Broto J, Hindi N, Aguiar S Jr, Badilla-González R, Castro-Oliden V, Chacón M, et al. Sarcoma European and Latin American Network (SELNET) Recommendations on Prioritization in Sarcoma Care During the COVID-19 Pandemic. Oncologist. 2020 Sep 5;25(10):e1562–73.
DS RISalud
RD Mar 19, 2025